Serum β2-microglobulin and prediction of progression to AIDS in HIV infection
- 13 June 1992
- journal article
- Published by Elsevier in The Lancet
- Vol. 339 (8807), 1436-1440
- https://doi.org/10.1016/0140-6736(92)92030-j
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- β2-microglobulin levels in drug usersAIDS, 1991
- Immune activation markers and AIDS prognosisAIDS, 1991
- Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1991
- Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.BMJ, 1990
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Serum beta2-microglobulin level increases in HIV infectionAIDS, 1990
- The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- The Risk ofPneumocystis cariniiPneumonia among Men Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- Serum 2-Microglobulin Decreases in Patients with AIDS or ARC Treated with AzidothymidineThe Journal of Infectious Diseases, 1989
- Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.BMJ, 1987